Health Benefits of Tart Cherry in Crohn's Disease
Not applicable · Testing Montmorency tart cherry · Sites not listed yet · University of Central Lancashire
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing Montmorency tart cherry (a dietary supplement) as a possible treatment. Condition(s) listed: Crohn Disease (CD).
Participants are assigned to groups by chance (randomized).
Some participants receive a placebo or sham for comparison.
It is blinded: participants and the study team do not know who receives what.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 to 65
- Any sex
Some of the main requirements, copied from the record:
- An established diagnosis of CDfor at least 6 months
- Current mild to moderate disease activity
- Age between 18 and 65 years
Plus 1 more requirement(s). There are also 6 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 52 participants are expected to take part.
- Start date: 2026-01-01 (planned).
- Main results expected around 2027-06-01 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Inflammatory Bowel Disease Quality of Life Questionnaire (This parameter will be examined at baseline.)
In the researchers’ words
Crohn's disease (CD) is a long-term inflammatory condition of the digestive tract. People with CD often experience unpredictable and debilitating symptoms, including abdominal pain, diarrhea, and fatigue.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Crohn Disease (CD) |
| Lead sponsor | University of Central Lancashire |
| Collaborators | University of Hertfordshire |
| Enrollment | 52 (estimated) |
| Start date | 2026-01-01 |
| Primary completion (est.) | 2027-06-01 |
| First posted | 2025-03-30 |
| Last updated | 2025-03-30 |
| Official title | Health Benefits of Montmorency Tart Cherry Juice Supplementation in Adults with Mild to Moderate Crohn's Disease. |
| ClinicalTrials.gov ID | NCT06901986 |
Interventions
- Montmorency tart cherry (Dietary Supplement)
Montmorency tart cherry 60ml per day for 6 weeks. - Placebo (Dietary Supplement)
Taste matched placebo.
Full eligibility criteria (from the record)
Inclusion Criteria: * An established diagnosis of CDfor at least 6 months * Current mild to moderate disease activity * Age between 18 and 65 years * Stable use of medication for at least 3 months respectively. Exclusion Criteria: * Diabetes * HIV * Hepatitis B and C infection * Abscesses * Unstable medical conditions that would likely prevent the subject from completing the study * Food allergies to cherries.
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.